A Phase I Study of Sunitinib in Combination With S-1 and Cisplatin in Patients With Advanced or Metastatic Gastric Cancer.
Phase of Trial: Phase I
Latest Information Update: 21 Mar 2015
At a glance
- Drugs Sunitinib (Primary) ; Cisplatin; Gimeracil/oteracil/tegafur
- Indications Gastric cancer
- Focus Adverse reactions
- Sponsors Pfizer
- 06 Mar 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 21 Jan 2014 Planned End Date changed from 1 Mar 2014 to 1 Mar 2015 as per ClinicalTrials.gov record.
- 01 Jul 2013 Planned end date changed from 1 Sep 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.